Published in Gene Ther on April 07, 2011
Gene therapy to treat cardiovascular disease. J Am Heart Assoc (2013) 1.13
Will we ever use stem cells for the treatment of SUI? ICI-RS 2011. Neurourol Urodyn (2012) 1.02
Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther (2014) 0.95
Treatment of bladder dysfunction using stem cell or tissue engineering technique. Korean J Urol (2014) 0.92
The evolution of heart gene delivery vectors. J Gene Med (2011) 0.92
Gene therapy for the treatment of heart failure: promise postponed. Eur Heart J (2016) 0.91
Chemokines and chemokine receptors: update on utility and challenges for the clinician. Surgery (2014) 0.89
Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression. Stem Cell Res (2015) 0.88
Adult Mesenchymal Stem Cells: When, Where, and How. Stem Cells Int (2015) 0.87
Coronary collateral growth--back to the future. J Mol Cell Cardiol (2011) 0.87
Stem cell therapy for incontinence: where are we now? What is the realistic potential? Curr Urol Rep (2011) 0.83
Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model. Circ Res (2013) 0.83
Impact of parturition on chemokine homing factor expression in the vaginal distention model of stress urinary incontinence. J Urol (2012) 0.82
Dipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular Disease. Front Immunol (2015) 0.82
Increase of circulating stromal cell-derived factor-1 in heart failure patients. Herz (2014) 0.81
Stem cell therapy for voiding and erectile dysfunction. Nat Rev Urol (2012) 0.81
Functional outcome after anal sphincter injury and treatment with mesenchymal stem cells. Stem Cells Transl Med (2014) 0.80
Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid. Int J Mol Sci (2015) 0.79
Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure. Am J Transl Res (2016) 0.75
CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman's Syndrome. Mol Ther Methods Clin Dev (2017) 0.75
Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia. Respir Res (2017) 0.75
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81
Direct gene transfer into mouse muscle in vivo. Science (1990) 10.39
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A (1994) 8.13
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet (2003) 6.85
Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol (2002) 3.61
SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J (2007) 3.01
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation (2003) 2.97
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation (2007) 2.88
Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept (2004) 2.56
Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med (1996) 2.42
Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation (2007) 2.35
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation (2009) 2.30
Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation (2007) 2.07
Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant (2003) 1.66
Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol (2007) 1.61
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest (1996) 1.57
Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation (1994) 1.45
Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation (2002) 1.32
Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res (2006) 1.22
SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis (2008) 1.16
SDF-1 recruits cardiac stem cell-like cells that depolarize in vivo. Cell Transplant (2007) 1.16
Time course of gene expression after plasmid DNA gene transfer to the liver. J Gene Med (2001) 1.10
Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction. Cell Transplant (2009) 1.05
Mechanical and electrical effects of cell-based gene therapy for ischemic cardiomyopathy are independent. Hum Gene Ther (2006) 1.04
Positron-emission tomography reporter gene expression imaging in rat myocardium. Circulation (2003) 1.03
Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment. Regul Pept (2005) 0.95
Bone marrow stem cells implantation with alpha-cyclodextrin/MPEG-PCL-MPEG hydrogel improves cardiac function after myocardial infarction. Acta Biomater (2009) 0.94
Non-viral vectors for gene therapy: clinical trials in cardiovascular disease. Adv Genet (2005) 0.85
Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? Cardiovasc Res (2006) 0.84
Liposome-mediated gene transfer into human vascular smooth muscle cells. Circulation (1994) 0.84
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
A real-time ratiometric method for the determination of molecular oxygen inside living cells using sol-gel-based spherical optical nanosensors with applications to rat C6 glioma. Anal Chem (2001) 2.48
CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol (1999) 2.43
Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation (2001) 2.12
Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly--data from the Cardiovascular Health Study. Radiology (1997) 1.90
Nucleotide sequence and genome organization of canine parvovirus. J Virol (1988) 1.76
Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system. J Bacteriol (2000) 1.70
Impact of folivory on photosynthesis is greater than the sum of its holes. Proc Natl Acad Sci U S A (2002) 1.61
Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull (2001) 1.53
Factorial structure of the Scale of Prodromal Symptoms. Schizophr Res (2004) 1.47
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res (2003) 1.47
The rapid isolation of ribonuclease-free immunoglobulin G by protein A-sepharose affinity chromatography. J Immunol Methods (1978) 1.44
Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr Res (2004) 1.42
Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine. Antimicrob Agents Chemother (1998) 1.21
Optical mapping in a new guinea pig model of ventricular tachycardia reveals mechanisms for multiple wavelengths in a single reentrant circuit. Circulation (1996) 1.18
SDF-1 in myocardial repair. Gene Ther (2012) 1.18
Comparison of nursing interventions classification and current procedural terminology codes for categorizing nursing activities. Image J Nurs Sch (1997) 1.11
The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2'-deoxy-3'-thiacytidine and a reduced ability to synthesize viral DNA. Antimicrob Agents Chemother (1998) 1.09
The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues. Antivir Chem Chemother (1998) 1.08
Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway. Biochim Biophys Acta (2000) 1.07
New hypothesis helps explain elasmobranch "outburst" on Georges Bank in the 1980s. Ecol Appl (2008) 1.04
Sensitivities of noninvasive tests for central nervous system vasculitis: a comparison of lumbar puncture, computed tomography, and magnetic resonance imaging. J Rheumatol (1994) 1.03
Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1. J Biol Chem (1999) 1.03
Dual origin of the vertebral artery mimicking dissection. AJNR Am J Neuroradiol (1997) 1.01
Platinate toxicity: past, present, and prospects. Cancer Treat Rep (1980) 0.98
The "prodromal" patient: both symptomatic and at-risk. CNS Spectr (2001) 0.98
Easy-to-use equipment for the accurate microinjection of nanoliter volumes into the nuclei of amphibian oocytes. Anal Biochem (1981) 0.97
Exogenous oxidized low-density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ Res (1997) 0.97
Characterization of erythrocyte quality during the refrigerated storage of whole blood containing di-(2-ethylhexyl) phthalate. Blood (1984) 0.95
Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptors. Am J Physiol Heart Circ Physiol (2008) 0.95
A phylogeny of the temperate seabasses (Moronidae) characterized by a translocation of the mt-nd6 gene. J Fish Biol (2011) 0.92
In Vitro Synthesis and Processing of Wheat alpha-Amylase : TRANSLATION OF GIBBERELLIC ACID-INDUCED WHEAT ALEURONE LAYER RNA BY WHEAT GERM AND XENOPUS LAEVIS OOCYTE SYSTEMS. Plant Physiol (1982) 0.90
Biological evaluation of glycoproteins mapping to two distinct mRNAs within the BamHI fragment 7 of pseudorabies virus: expression of the coding regions by vaccinia virus. Virology (1989) 0.90
The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines. Vaccine (1991) 0.89
Characterization of chimeric lipopolysaccharides from Escherichia coli strain JM109 transformed with lipooligosaccharide synthesis genes (lsg) from Haemophilus influenzae. J Biol Chem (2000) 0.89
Estimated yield of early detection of prodromal or first episode patients by screening first degree relatives of schizophrenic patients. Schizophr Res (2001) 0.88
Characterization of two transposon mutants from Haemophilus influenzae type b with altered lipooligosaccharide biosynthesis. Biochemistry (1996) 0.87
Tissue distribution and histopathological effects of titanium dioxide nanoparticles after intravenous or subcutaneous injection in mice. J Appl Toxicol (2011) 0.86
In vivo catenation and decatenation of DNA. Mol Cell Biol (1983) 0.85
Carotid thromboendarterectomy for recent total occlusion of the internal carotid artery. J Vasc Surg (2001) 0.83
Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes (1992) 0.81
Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling. Circ Res (2001) 0.81
A comparison of nursing intervention classification and current procedural terminology codes for representing nursing interventions in HIV disease. Medinfo (1995) 0.80
Amino acid requirements of a rat sarcoma as determined by a stem cell assay. JPEN J Parenter Enteral Nutr (1987) 0.80
Polyamines found in gingival fluid inhibit chemotaxis by human polymorphonuclear leukocytes in vitro. J Periodontol (1995) 0.78
Pregnancy at teenage--risk factor for lower birth weight. Indian Pediatr (1989) 0.78
The relationship between repetition and depth of processing. Mem Cognit (1976) 0.78
Cleft palate formation: a role for pyridoxine in the closure of the secondary palate in mice. Teratology (1972) 0.78
Characterization of immune response to Eimeria tenella antigens in a natural immunity model with hosts which differ serologically at the B locus of the major histocompatibility complex. Infect Immun (1997) 0.78
Sterically hindered C(alpha, alpha)-disubstituted alpha-amino acids: synthesis from alpha-nitroacetate and incorporation into peptides. J Org Chem (2001) 0.77
Cloning and expression of FECV spike gene in vaccinia virus. Immunization with FECV S causes early death after FIPV challenge. Adv Exp Med Biol (1995) 0.77
Effects of hypertension and aging on coronary arteriolar density. Hypertension (1993) 0.76
Chemical evolution of the citric acid cycle: sunlight photolysis of the amino acids glutamate and aspartate. Orig Life Evol Biosph (1992) 0.76
Sounding out leaders of the PACs. Roundtable discussion. Healthc Inform (1995) 0.75
Ionic iodinated contrast medium and amobarbital sodium mixtures: potential for precipitation. Radiology (1992) 0.75
Virus inactivation in hemoglobin solutions by heat. Biomater Artif Cells Artif Organs (1988) 0.75
Effects of age on the adaptive behavior of institutionalized and noninstitutionalized individuals with Down syndrome. Am J Ment Retard (1988) 0.75
Effect of dietary administration of the rubber curative trithiocyanuric acid to the rat. Food Chem Toxicol (1983) 0.75
Optimization of erythrocyte membrane glycoprotein fluorescent labeling with dansylhydrazine after polyacrylamide gel electrophoresis. Anal Biochem (1986) 0.75
Nadolol: placental transfer and excretion in the milk of rats. Toxicol Appl Pharmacol (1977) 0.75
Effect of Buckberg cardioplegia and peripheral cardiopulmonary bypass on infarct size in the closed chest dog. J Am Coll Cardiol (1992) 0.75
Cleft palate formation: the effects of fasting and iodoacetic acid on mice. Teratology (1973) 0.75
Mass radiography service. Annual report of the Glasgow service for 1968. Health Bull (Edinb) (1970) 0.75
Serological recognition of feline infectious peritonitis virus spike gene regions expressed as synthetic peptides and E. coli fusion protein. Arch Virol (1995) 0.75
Nodular fasciitis. A podiatric review and report of a case. J Am Podiatry Assoc (1976) 0.75
Quantitative evaluation of local drug delivery using the InfusaSleeve catheter. Cathet Cardiovasc Diagn (1997) 0.75
Using 30-cluster survey to assess neonatal and perinatal mortality. World Health Forum (1991) 0.75
Long-term feeding studies in mice fed a diet containing irradiated fish. II. 90-Day toxicity study. Toxicol Lett (1980) 0.75
Oestrogen and transplant vascular disease. Clin Exp Pharmacol Physiol (1999) 0.75
The purification of hemoglobin solutions by heating. Prog Clin Biol Res (1989) 0.75
A pilot survey of nail surgery. J Am Podiatry Assoc (1968) 0.75
Angiotensin-converting enzyme inhibition produces electrophysiologic but not antiarrhythmic effects in the intact heart. J Cardiovasc Pharmacol (1998) 0.75